Search results for "Drug Safety"
Changes to contraindication for statins in pregnancy
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/09/changes-to-contraindication-for-statins-in-pregnancy.htm
1 Sep 2021
Pulmonary illnesses linked to e-cigarette products
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/11/pulmonary-illnesses-linked-to-e-cigarette-products.htm
1 Nov 2019
Polypill gets approval, fenofibric acid gets label change
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/01/fda.htm
1 Jan 2012
Managing medications in patients with heart failure
Internists can provide a medical home to patients with heart failure so that medications and supplements are regularly assessed and managed, according to experts.
https://immattersacp.org/archives/2017/02/medications.htm
1 Feb 2017
Ranitidine pulled from market; COVID-19 updates
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/06/ranitidine-pulled-from-market-covid-19-updates.htm
1 Jun 2020
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
Recommended: Move hydrocodone combo products to schedule II
This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014
Warning on PPIs and C. diff, contraceptive pill mixup
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/04/fda.htm
1 Apr 2012
New COPD treatment, warnings on insomnia and migraine drugs
This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more.
https://immattersacp.org/archives/2013/07/fda.htm
1 Jul 2013
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012